Genetic Testing Stock Nears Buy Point After Earnings Gap Up And 43% Gain
Natera stock has outperformed the S&P 500 year to date and is near a buy point after earnings. Natera provides…
172,500€
0,29%
Echtzeit-Aktienkurs Natera Inc.
Bid:
Ask:
Nachrichten zur Natera Inc. Aktie
Natera enters partnership for French colorectal cancer trial By Investing.com
Natera enters partnership for French colorectal cancer trial…
Natera CEO executes stock transactions valued over $8.7 million By Investing.com
Natera CEO executes stock transactions valued over $8.7 million…
5 Small Biotech ETFs to Watch (Updated 2024)
Thanks to exchange-traded funds (ETFs), investors don’t have to be tied to one specific stock. Biotech ETFs allow market participants…
Final Trades: Natera, Disney, Chubb and ASML Holding
The Investment Committee share their top stocks to watch for he second half.…
Natera: Kurszielerhöhung
Zürich (www.aktiencheck.de) - Rating-Update:
Dan Leonard, Analyst der UBS, bewertet die Aktie von Natera Inc. (ISIN: US6323071042, WKN: A14VPJ, Ticker-Symbol: 45E,…
Earnings call: Natera Inc. surpasses Q4 expectations, eyes growth By Investing.com
Earnings call: Natera Inc. surpasses Q4 expectations, eyes growth…
Natera, Inc. (NTRA) Q4 2023 Earnings Call Transcript
…
Nateras Signatera test expands Medicare coverage By Investing.com
Nateras Signatera test expands Medicare coverage…